View : 148 Download: 29
A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast Cancer
- Title
- A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast Cancer
- Authors
- Lee; Han-Byoel; Kyung-Hun; Song; Seok Hyun; Kim; Kyubo; Hong Kyu; Moon; Hyeong-Gon; Han; Wonshik; Dae-Won; Im; Seock-Ah; Jang; Bum-Sup; Yong Bae; Yu; Jonghan; Jee Hyun; Park; Yeon Hee; Shin; Kyung Hwan; Chang; Ji Hyun
- Ewha Authors
- 김규보
- SCOPUS Author ID
- 김규보
- Issue Date
- 2023
- Journal Title
- Oncologist
- ISSN
- 1083-7159
- Citation
- Oncologist vol. 28, no. 12, pp. e1142 - e1151
- Keywords
- breast cancer; chemotherapy; neoadjuvant therapy; radiotherapy; staging; surgery
- Publisher
- Oxford University Press
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Background: The importance of clinical staging in breast cancer has increased owing to the wide use of neoadjuvant systemic therapy (NST). This study aimed to investigate the current practice patterns regarding clinical nodal staging in breast cancer in real-world settings. Materials and Methods: A web-based survey was administered to board-certified oncologists in Korea, including breast surgical, medical, and radiation oncologists, from January to April 2022. The survey included 19 general questions and 4 case-based questions. Results: In total, 122 oncologists (45 radiation, 44 surgical, and 33 medical oncologists) completed the survey. Among them, 108 (88%) responded that clinical staging before NST was primarily performed by breast surgeons. All the respondents referred to imaging studies during nodal staging. Overall, 64 (52.5%) responders determined the stage strictly based on the radiology reports, whereas 58 (47.5%) made their own decision while noting radiology reports. Of those who made their own decisions, 88% referred to the number or size of the suspicious node. Of the 75 respondents involved in prescribing regimens for neoadjuvant chemotherapy, 58 (77.3%) responded that the reimbursement regulations in the selection of NST regimens affected nodal staging in clinical practice. In the case-based questions, high variability was observed among the clinicians in the same cases. Conclusions: Diverse assessments by specialists owing to the lack of a clear, harmonized staging system for the clinical nodal staging of breast cancer can lead to diverse practice patterns. Thus, practical, harmonized, and objective methods for clinical nodal staging and for the outcomes of post-NST response are warranted for appropriate treatment decisions and accurate outcome evaluation. © 2023 The Author(s). Published by Oxford University Press.
- DOI
- 10.1093/oncolo/oyad156
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
-
oyad156.pdf(1.7 MB)
Download
- Export
- RIS (EndNote)
- XLS (Excel)
- XML